Too much damage to the balance sheet, from the losses. It's great that they sold new debt, and bought more breathing space....but when the upturn comes, how much additional interest expense are they going to have to pay, to fund the growth in the company from increased receivables and inventories?

I'm a buyer at $2. Maybe $4. Not at $10.

Considering the financial risk, who the hell would want to own it at $10, when the 12-18 month upside is maybe $20. I can find a lot of better situations, with HIGHER upside potential, and LESS risk, than BC. Sure, they are draining the pipeline, and sales are going to come back very nicely next year....but the damage to the balance sheet has already been done....and one wonders if, on any further increase in the stock price if they'd be tempted to do something like issuing maybe 40 million shares at $10, to build up equity. Frankly, they probably NEED to.....and I wonder why management didn't do that when it moved up to $11-13 a few weeks back.

I think this stock is ahead of itself. A drop to, and getting stuck in an $8-10 trading range would probably be the healthiest thing that could happen here.

Yes, for those who are wondering, I've kind of changed my tune here. We're looking at another huge loss in the Dec. quarter.....with tangible equity being pretty much NONEXISTENT at the end of Q4. Long-term hold, at BEST.

I'd much rather own something like FBN (one of my largest positions).